Discovery of novel dual c-Met/HDAC inhibitors as a promising strategy for cancer therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of novel dual c-Met/HDAC inhibitors as a promising strategy for cancer therapy

Published:2020-08 Issue: Volume:101 Page:103970
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Hu Hao,Chen Fei,Dong Yuhong,Liu Yajing,Gong Ping

Funder

National Natural Science Foundation of China

LiaoNing Revitalization Talents Program

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference39 articles.

1. Kinase Inhibitor Drugs;Claiborne,2009

2. The enzymatic phosphorylation of proteins;Burnett;J. Biol. Chem.,1954

3. Acquired resistance of lung adenocarcinomas to Gefitinib or Erlotinib is associated with a second mutation in the EGFR kinase domain;Pao;PLoS Med.,2015

4. Comparison of the EGFR resistance mutation profiles generated by EGFR-targeted tyrosine kinase inhibitors and the impact of drug combinations;Avizienyte;Biochem. J.,2008

5. Overview on anticancer drug design and development;Olgen;Curr. Med. Chem.,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of class I HDAC modulators: Inhibitors and degraders;European Journal of Medicinal Chemistry;2024-10

2. Design and Synthesis of c-Met and HDAC Dual Inhibitors for the Treatment of Breast Cancer;ACS Medicinal Chemistry Letters;2024-08-22

3. Discovery of 2-Methyl-5-(1H-pyrazol-4-yl)pyridines and Related Heterocycles as Promising M₄ mAChR Positive Allosteric Modulators for the Treatment of Neurocognitive Disorders;Journal of Medicinal Chemistry;2024-07-18

4. Recent advances in c-Met-based dual inhibitors in the treatment of cancers;European Journal of Medicinal Chemistry;2024-06

5. Design, Synthesis, and Herbicidal Evaluation of Pyrrolidinone-Containing 2-Phenylpyridine Derivatives as Novel Protoporphyrinogen Oxidase Inhibitors;Journal of Agricultural and Food Chemistry;2024-04-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3